The shares of Zimmer Biomet Holdings, Inc. have decreased by more than -6.43% this year alone. The shares recently went up by 0.82% or $0.92 and now trades at $112.91. The shares of Tenet Healthcare Corporation (NYSE:THC), has jumped by 58.38% year to date as of 12/06/2018. The shares currently trade at $24.01 and have been able to report a change of -6.32% over the past one week.
The stock of Zimmer Biomet Holdings, Inc. and Tenet Healthcare Corporation were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.Next 5Y EPS Growth: 4.38% versus 5.00%
When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that ZBH will grow it’s earning at a 4.38% annual rate in the next 5 years. This is in contrast to THC which will have a positive growth at a 5.00% annual rate. This means that the higher growth rate of THC implies a greater potential for capital appreciation over the years.Profitability and Returns
Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. ZBH has an EBITDA margin of 22.98%, this implies that the underlying business of ZBH is more profitable. The ROI of ZBH is 4.00% while that of THC is 6.60%. These figures suggest that THC ventures generate a higher ROI than that of ZBH.Cash Flow
The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, ZBH’s free cash flow per share is a positive 3.75, while that of THC is positive 1.05.Liquidity and Financial Risk
The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for ZBH is 1.90 and that of THC is 1.10. This implies that it is easier for ZBH to cover its immediate obligations over the next 12 months than THC.Valuation
ZBH currently trades at a forward P/E of 14.41, a P/B of 1.88, and a P/S of 2.90 while THC trades at a forward P/E of 12.50, and a P/S of 0.13. This means that looking at the earnings, book values and sales basis, ZBH is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.Analyst Price Targets and Opinions
The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of ZBH is currently at a -16.26% to its one-year price target of 134.84. Looking at its rival pricing, THC is at a -20.26% relative to its price target of 30.11.
When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), ZBH is given a 2.30 while 2.70 placed for THC. This means that analysts are more bullish on the outlook for THC stocks.Insider Activity and Investor Sentiment
Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for ZBH is 2.43 while that of THC is just 7.80. This means that analysts are more bullish on the forecast for ZBH stock.
The stock of Zimmer Biomet Holdings, Inc. defeats that of Tenet Healthcare Corporation when the two are compared, with ZBH taking 5 out of the total factors that were been considered. ZBH happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, ZBH is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for ZBH is better on when it is viewed on short interest.